IOL type increases capsular block risk

Article

The incidence of capsular block syndrome (CBS), although rare, can be increased by design features of lenses implanted during cataract surgery, according to a study published in the March 2008 issue of the Journal of Cataract & Refractive Surgery.

The incidence of capsular block syndrome (CBS), although rare, can be increased by design features of lenses implanted during cataract surgery, according to a study published in the March 2008 issue of the Journal of Cataract & Refractive Surgery.

Hong Kyun Kim, MD and Jae Pil Shin, MD, PhD of the Department of Ophthalmology, Kyungpook National University, Daegu, Republic of Korea reviewed 990 patients (1100 eyes) implanted with posterior chamber intraocular lenses (PC IOLs) following cataract surgery in the period January 2003–June 2006.

The incidence of postoperative CBS (which was classified as noncellular, inflammatory or fibrotic) was 0.73% (n=8). Statistically significant risk factors for CBS development were identified as longer axial length (AL; odds ratio, 5.75) and the implantation of a four-haptic PC IOL (Akreos Adapt, Bausch & Lomb; odds ratio, 7.388).

The researchers concluded that AL and PC IOL design features could increase the likelihood of postoperative CBS development.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.